-
公开(公告)号:US10407501B2
公开(公告)日:2019-09-10
申请号:US15110414
申请日:2015-01-08
Applicant: GENMAB A/S
Inventor: Edward Norbert Van Den Brink , Joost J. Neijssen , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Isil Altintas , Paul Parren , Rik Rademaker
Abstract: The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
-
公开(公告)号:US20140303356A1
公开(公告)日:2014-10-09
申请号:US14353962
申请日:2012-10-26
Applicant: GENMAB A/S
Inventor: Michael Gramer , Amitava Kundu , Ewald T. J. Van Den Bremer , Muriel Van Kamper , Patrick Priem , Aran Frank Labrijn , Joyce I. Meesters , Joost J. Neijssen , Janine Schuurman , Paul Parren , Patrick Van Berkel , Werner L. Vos , Arnout Gerritsen
CPC classification number: C07K1/1133 , C07K16/2863 , C07K16/2887 , C07K16/468 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/55 , C07K2317/732 , C07K2317/734 , C07K2317/90
Abstract: The present invention relates to an in vitro method for production of heterodimeric proteins.
Abstract translation: 本发明涉及用于生产异二聚体蛋白质的体外方法。
-
公开(公告)号:US11578141B2
公开(公告)日:2023-02-14
申请号:US16667369
申请日:2019-10-29
Applicant: GENMAB A/S
Inventor: Joost J. Neijssen , Joyce I. Meesters , Bart De Goeij , Aran Frank Labrijn , Paul Parren , Janine Schuurman
Abstract: Bispecific antibodies which comprise one antigen-binding region binding to an epitope of human epidermal growth factor receptor 2 (HER2) and one antigen-binding region binding to human CD3, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods for preparing and using the antibodies are also disclosed.
-
公开(公告)号:US11512140B2
公开(公告)日:2022-11-29
申请号:US16548883
申请日:2019-08-23
Applicant: GENMAB A/S
Inventor: Joost J. Neijssen , Bart De Goeij , Edward Norbert Van Den Brink , Aran Frank Labrijn , Rene Hoet , Janine Schuurman , Paul Parren , Jan Van De Winkel
IPC: C07K16/30 , G01N33/574 , A61P35/00 , A61K39/395 , C07K16/28 , A61K45/06 , C07K16/40 , A61K39/00
Abstract: Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
-
公开(公告)号:US11485796B2
公开(公告)日:2022-11-01
申请号:US16783720
申请日:2020-02-06
Applicant: GENMAB A/S
Inventor: Aran Frank Labrijn , Joyce I. Meesters , Joost J. Neijssen , Edward Norbert Van Den Brink , Janine Schuurman , Paul Parren
Abstract: Described herein are, proteins comprising amino acid substitutions in at least one of a first and a second polypeptide chain. Furthermore, is described the uses and methods related to said proteins.
-
公开(公告)号:US10544220B2
公开(公告)日:2020-01-28
申请号:US15541594
申请日:2016-01-08
Applicant: GENMAB A/S
Inventor: Patrick Engelberts , Esther Breij , Rik Rademaker , Isil Altintas , David Satijn , Sandra Verploegen , Riemke Van Dijkhuizen Radersma , Edward Van Den Brink , Janine Schuurman , Paul Parren
IPC: C07K16/28 , C07K16/30 , A61K39/395 , A61K39/00
Abstract: Bispecific antibodies directed to CD3 and CD20 and uses of such bispecific antibodies, in particular use thereof in the treatment of diseases in which specific targeting and T cell-mediated killing of cells that express CD20 is desired.
-
公开(公告)号:US10351629B2
公开(公告)日:2019-07-16
申请号:US15072983
申请日:2016-03-17
Applicant: GENMAB A/S
Inventor: Janine Schuurman , Tom Vink , Jan Van De Winkel , Aran Frank Labrijn , Paul Parren , Willem Karel Bleeker , Frank Beurskens , Patrick Van Berkel
Abstract: The invention relates to novel non-human transgenic animals, which upon antigenic stimulation are capable of producing monovalent antibodies binding to a selected antigen, modified heavy chain transgenes, methods for producing the non-human transgenic animals, methods for immunizing the non-human transgenic animals for as well as monovalent antibodies obtainable by such immunization methods.
-
公开(公告)号:US12247065B2
公开(公告)日:2025-03-11
申请号:US17253286
申请日:2019-06-24
Applicant: GENMAB A/S
Inventor: Richard Hibbert , Rob De Jong , Aran Frank Labrijn , Arnout Gerritsen , Janine Schuurman , Paul Parren
Abstract: The present invention relates to a method for controlling the composition of a mixture of two or more different antibodies, such as tow or more different monoclonal antibodies, using chromatography. The mixture is for use as a drug product and the method includes a controlled downstream process for the production of a predetermined ratio of the two or more different antibodies.
-
公开(公告)号:US20240084036A1
公开(公告)日:2024-03-14
申请号:US17972867
申请日:2022-10-25
Applicant: Genmab A/S
Inventor: Joost J. NEIJSSEN , Bart De Goeij , Edward Norbert Van Den Brink , Aran Frank Labrijn , Rene Hoet , Janine Schuurman , Paul Parren , Jan Van De Winkel
IPC: C07K16/30 , A61K39/395 , A61K45/06 , A61P35/00 , C07K16/28 , C07K16/40 , G01N33/574
CPC classification number: C07K16/3076 , A61K39/3955 , A61K45/06 , A61P35/00 , C07K16/2863 , C07K16/40 , G01N33/5748 , A61K2039/505 , C07K2317/31 , C07K2317/35 , C07K2317/524 , C07K2317/526 , C07K2317/565 , C07K2317/71 , G01N2333/912
Abstract: Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
-
公开(公告)号:US11613575B2
公开(公告)日:2023-03-28
申请号:US16544376
申请日:2019-08-19
Applicant: GENMAB A/S
Inventor: Edward Norbert Van Den Brink , Joost J. Neijssen , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Isil Altintas , Paul Parren , Rik Rademaker
Abstract: The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
-
-
-
-
-
-
-
-
-